Astra Enters Obesity Drug Race With Chinese Biotech Deal

China Healthcare Stocks On Recovery Path After $142 Billion Rout

New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper

Asian Stocks to Climb as S&P 500 Hits Hot Streak: Markets Wrap

Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic

Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs

Apple, McDonald’s, Airbnb Earnings Set to Strip Away GDP Gloss

Eisai Alzheimer Drug Shows Promise in Injected-At-Home Form